Core Technology Investment and Development Forum

1. Launch of Zhongguancun Future Industry Fund 

2. Release of the List of Top Technology Investment Institutions in Zhongguancun

3. Strategic Cooperation Signing Ceremony for Original Technology Forces Projects

Part 1: Frontier Trends and Investment Opportunities in Core Technology

1.Synthetic Biology: From Cutting-Edge Technology to Industrial Transformation — Tan Tianwei, Academician of the Chinese Academy of Engineering

2.Brain Science: Exploring the Mysteries of the Brain and the Future of Intelligent Technology — Luo Minmin, Director of Chinese Institute for Brain Research, Beijing

Part 2: New Productive Forces: Investing in Technology to Drive Upgrades

1.Diversified Technology Investment from a Global Perspective — Fahad Alarjani, General Manager of International Relations, National Industrial Development and Logistics Program (NIDLP), Saudi Arabia

2.Core Technology Investment Driving New Productive Forces — Feng Junfu, Chairman of ICBC

Part 3: Core Technology Enterprises: Competition and Development

1.Intelligent Evolution: Innovations and Breakthroughs in Humanoid Robotics

Part 4: The Path of Patient Capital in Insurance Funds

1.Technology Finance Empowerment: Asset Allocation Strategies for Insurance Funds in the Core Technology Era — Yang Yucheng, Chairman of New China Life Insurance

Part 1: The Underlying Logic of Investment and Mergers in Core Technology

Host: Li Bin, Chairman of Unigroup Co., Ltd.

Guests:

1.Li Hong, Secretary of the Board, GigaDevice

2.Sun Zheng, Partner at KKR Group

3.Shan Junbao, Chairman of CICC

Part 2: Global Layout and Industry Chain Development for Core Technology Enterprises

Host: Lu Peng, Deputy General Manager of ZGC International Holding Ltd.

Guests:

1.Dr Jack Lau, President of Qatar Science and Technology Park

2.Friedemann Stuetz, Director of Trimeta Research Institute, Founder of Trimeta Software, Germany

3.Xu Jingjing, Partner at Fuel Ventures, UK

4.Jason Saw Koon Khim, Head of Investment Banking, CGS International, Singapore

5.Markus Gerhard, Head of TUM Biotech Venture Lab, Germany